Page 119 - GTM-3-4
P. 119

Global Translational Medicine                                    Sleep apnea in patients with tachyarrhythmias




            Table 1. Characteristics of the study population
            Characteristics                                       Group I (n=155) (%)  Group II (n=52) (%)  P‑value
            Age (years), mean (IQR)                               64 (58 – 69)       57 (52 – 66)       0.001
            Sex, n (%)                                                                                  0.156
             Female                                               58 (28.02)         25 (12.08)
             Male                                                 97 (46.86)         27 (13.04)
            Height (cm), mean (IQR)                               174 (166 – 179)    174.5 (164.5 – 181)  0.999
            Weight (kg), mean (IQR)                               100 (89 – 115)     95.5 (85 – 110)    0.092
            BMI (kg/m ), mean (IQR)                               34 (30.4 – 38)     31.65 (27.95 – 35.72)  0.027
                   2
            BSA (m ), mean (IQR)                                  2.182 (2.05 – 2.34)  2.133 (2.01 – 2.31)  0.173
                 2
            Waist circumference (cm), mean (IQR)                  114 (107 – 124.5)  108 (100.5 – 115.5)  0.001
            Neck circumference (cm), mean (IQR)                   43 (40.85 – 46)    41 (39 – 43)       0.001
            Risk of CVD as assessed by SCORE2 (patients age 40 – 69 years) or   13 (7 – 18)  10 (7 – 15)  0.254
            SCORE-OP (patients age >70) (%), mean (IQR)
            Hypertension, n (%)                                   137 (66.18)        43 (20.77)         0.448
            Type-2 diabetes, n (%)                                59 (28.51)         8 (3.86)           0.003
            Heart failure, n (%)                                  79 (38.16)         14 (6.76)          0.004
            NYHA Class I,                                         12 (5.79)          1 (0.48)           0.33
            NYHA Class II,                                        51 (24.64)         12 (5.79)          0.249
            NYHA Class III,                                       16 (7.73)          1 (0.48)           0.06
            Previous myocardial infarction, n (%)                 11 (5.32)          1 (0.48)           0.17
            Previous ischemic stroke or TIA, n (%)                3 (1.45)           4 (1.93)           0.045
            Hospital anxiety and depression scale (HADS) score (Part I), mean (IQR)  4 (2 – 7)  5 (3 – 8)  0.065
            Borderline anxiety, n (%)                             17 (8.22)          9 (4.35)           0.093
            Anxiety, n (%)                                        5 (2.43)           2 (0.97)           0.684
            Hospital anxiety and depression scale (HADS) score (Part II), mean (IQR)  4 (2 – 7)  4 (2 – 6)  0.757
            Borderline depression, n (%)                          12 (5.79)          3 (1.45)           0.82
            Depression, n (%)                                     6 (2.89)           4 (1.93)           0.164
            Abbreviations: BMI: Body mass index; BSA: Body surface area; CVD: Cardiovascular disease; IQR: Interquartile range; NYHA: New York Heart
            Association; TIA: Transient ischemic attack.

               sleepiness, respectively. One of the most common   study. Mild, moderate, and severe OSA is defined as 5 –
               symptoms of OSA is daytime tiredness.           15, 15 – 30, and >30 episodes/h, respectively. The cohort
            (iv)  The HADS was used to assess anxiety and depression.   was divided into patients with OSA (Group I) and those
               A score of 0 – 7, 8 – 10, and 11 is considered normal,   without OSA (Group II).
               borderline anxiety or depression, and clinically   2.3. Statistical analysis
               significant anxiety or depression, respectively.
                                                               Data were analyzed using SPSS Statistics (version  26.0;
              After  the  screening  questionnaires  were  completed,   IBM, Armonk,  New  York, United States). Normality of
            RM was performed using a respiratory polygraph     distribution was determined using the Kolmogorov–
            (SOMNOtouch™ RESP eco; SOMNOmedics AG,             Smirnov  test.  Quantitative  variables  are  presented  as
            Randersacker, Germany).                            medians and IQRs due to the asymmetric distribution.
            2.2. Diagnosis of OSA                              Differences between the two groups were assessed using the
                                                               Mann–Whitney U-test. Qualitative variables are presented
            OSA severity was assessed according to the guidelines of   as absolute (n) and relative (%) values. In addition,
            the Russian Society of Sleep Medicine,  which is based on   receiver operating characteristic (ROC) curve analysis was
                                          24
            the apnea-hypopnea index (AHI). The AHI represents the   performed using curve construction. The AUC was used to
            average number of episodes (apnea) per hour of sleep or   quantify test significance. Spearman correlation was used


            Volume 3 Issue 4 (2024)                         3                               doi: 10.36922/gtm.5059
   114   115   116   117   118   119   120   121   122   123   124